117 related articles for article (PubMed ID: 14575376)
1. Comparison of gallium-67 citrate and technetium-99m tetrofosmin scan to detect Hodgkin's disease.
Liu FY; Shiau YC; Yen RF; Wang JJ; Ho ST; Kao CH
Ann Nucl Med; 2003 Sep; 17(6):439-42. PubMed ID: 14575376
[TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of technetium-99m tetrofosmin scan to detect non-Hodgkin's lymphoma.
Liu FY; Shiau YC; Kao A; Liang JA; Yang SN
Anticancer Res; 2003; 23(3C):2951-3. PubMed ID: 12926142
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
[TBL] [Abstract][Full Text] [Related]
5. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
[TBL] [Abstract][Full Text] [Related]
7. Predicting chemotherapy response and comparing with P-glycoprotein expression using technetium-99m tetrofosmin scan in untreated malignant lymphomas.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Lett; 2001 Sep; 170(2):139-46. PubMed ID: 11463491
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma.
Lee JK; Tsai SC; Ho YJ; Changlai SP; Kao CH
Anticancer Res; 2001; 21(2B):1509-13. PubMed ID: 11396241
[TBL] [Abstract][Full Text] [Related]
9. Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression.
Liang JA; Shiau YC; Yang SN; Lin FJ; Lin CC; Kao A; Lee CC
Oncol Rep; 2002; 9(2):307-12. PubMed ID: 11836597
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections.
Koukouraki S; Gaitanis I; Hatjipaulou A; Karkavitsas N
Hell J Nucl Med; 2006; 9(2):99-102. PubMed ID: 16894413
[TBL] [Abstract][Full Text] [Related]
11. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluation.
Maurea S; Acampa W; Varrella P; De Rosa V; Fimiani P; Abate G; Salvatore M
Clin Nucl Med; 1998 May; 23(5):283-90. PubMed ID: 9596152
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.
Sasaki M; Kuwabara Y; Koga H; Nakagawa M; Chen T; Kaneko K; Hayashi K; Nakamura K; Masuda K
Ann Nucl Med; 2002 Jul; 16(5):337-45. PubMed ID: 12230093
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts.
Yang MD; Sun SS; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(4):518-23. PubMed ID: 12094547
[TBL] [Abstract][Full Text] [Related]
15. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
16. Detection of cervical lymph node metastases of nasopharyngeal carcinomas with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Anticancer Res; 2001; 21(1B):723-6. PubMed ID: 11299833
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease. Prognostic value of Gallium-67 scintigraphy.
Hervás I; Segura A; López-Tendero P; Bello P; González-Cabezas P; Flores D; Yuste A; Pérez-Velasco R; Girones R; Mateo A
Q J Nucl Med; 2003 Jun; 47(2):101-8. PubMed ID: 12865870
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Wu HS; Liu FY; Huang WS; Liu YC; Chang CT; Kao CH
Clin Radiol; 2003 Oct; 58(10):787-90. PubMed ID: 14521888
[TBL] [Abstract][Full Text] [Related]
19. 67Ga-citrate imaging in untreated Hodgkin's disease: preliminary report of Cooperative Group.
Johnston G; Benua RS; Teates CD; Edwards CL; Kniseley RM
J Nucl Med; 1974 Jun; 15(6):399-403. PubMed ID: 4829199
[No Abstract] [Full Text] [Related]
20. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
